These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Action of isonicotinic acid hydrazide on strains of Mycobacterium tuberculosis]. GHIONE M Boll Soc Ital Biol Sper; 1952 May; 28(5):994-6. PubMed ID: 13018589 [No Abstract] [Full Text] [Related]
29. [Phenomenon of extinction and resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide]. ZEBROWSKI T; PIENIAZEK J; BOROWIECKA A Gruzlica (1926); 1954 Mar; 22(3):173-7. PubMed ID: 13183394 [No Abstract] [Full Text] [Related]
30. [In vitro and in vivo antituberculous action of isonicotinic acid hydrazide (isoniazide)]. REGINSTER A Rev Med Liege; 1953 May; 8(10):329-36. PubMed ID: 13101143 [No Abstract] [Full Text] [Related]
31. [Tuberculosis bacilli of weak virulence isolated after isoniazid therapy]. BERNARD E; KREIS B; LE JOUBIOUX E Rev Tuberc; 1955 Nov; 19(10-11):1113-44; discussion, 1185-7. PubMed ID: 13311186 [No Abstract] [Full Text] [Related]
33. The inactivation of isoniazid by filtrates and extracts of mycobacteria. YOUMANS AS; YOUMANS GP Am Rev Tuberc; 1955 Aug; 72(2):196-203. PubMed ID: 13238779 [No Abstract] [Full Text] [Related]
34. [Variation in oxygen consumption in tubercle bacillus and lung tissue induced by isoniazid and several of its derivatives]. CREMA A; GAFFURI P Boll Soc Ital Biol Sper; 1955; 31(9-10):1126-9. PubMed ID: 13329036 [No Abstract] [Full Text] [Related]
35. Differences between the effect of isonicotylhydrazide (neoteben, rimifon) in vitro and in guinea pigs. WILDE W Med Monatsschr; 1952 Nov; 6(11):706-7. PubMed ID: 13024743 [No Abstract] [Full Text] [Related]
36. Bacteriological control during isoniazid therapy. OGILVIE CM Lancet; 1953 Aug; 265(6783):451-2. PubMed ID: 13085812 [No Abstract] [Full Text] [Related]
37. The prevalence of streptomycin- and isoniazid-resistant strains of Mycobacterium tuberculosis in patients with newly discovered and untreated active pulmonary tuberculosis. CHAVES AD; ROBINS AB; ABELES H; PEIZER LR; DANGLER G; WIDELOCK D Am Rev Tuberc; 1955 Aug; 72(2):143-50. PubMed ID: 13238775 [No Abstract] [Full Text] [Related]
38. Mode of action of isoniazid. ALBERT A Nature; 1956 Mar; 177(4507):525-6. PubMed ID: 13321893 [No Abstract] [Full Text] [Related]
39. [Bacterial sensitivity in pulmonary tuberculosis under isonicotinic acid hydrazide therapy]. BEEUWKES H; ESSEVELD H Ned Tijdschr Geneeskd; 1952 Aug; 96(34):2061-4. PubMed ID: 13013355 [No Abstract] [Full Text] [Related]
40. CHANGES in isoniazid resistance of tubercle bacilli after cessation of treatment; report by the Laboratory Subcommittee of the Tuberculosis Chemotherapy Trials Committee, Medical Research Council; M.R.C. isoniazid trial: Report No. 6. Thorax; 1954 Dec; 9(4):254-9. PubMed ID: 13226306 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]